Iris Roth

Insider Reports History

Location
New York, NY
Signature
/s/ Andrea Paul, attorney-in-fact for Iris Roth
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Iris Roth:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Zentalis Pharmaceuticals, Inc. Chief Operating Officer Stock Option (Right to Buy) 298K $14.2M $47.80 01 Mar 2023 Direct
Zentalis Pharmaceuticals, Inc. Chief Operating Officer Common Stock 52.5K $540K $10.29 01 Mar 2023 Direct

Insider Reports Filed by Iris Roth

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ZNTL Zentalis Pharmaceuticals, Inc. 01 Mar 2023 2 $0 4 Chief Operating Officer 02 Mar 2023, 15:30
ZNTL Zentalis Pharmaceuticals, Inc. 13 Feb 2023 0 $0 3 Chief Operating Officer 13 Feb 2023, 06:07